IP Library Granted Patent US 39,821
Granted Patent E1
US 39,821 · App. 11/234,817 · Granted Sep 4, 2007

Manufacture and expression of large structural genes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 39,821
App. No.
11/234,817
Granted
Sep 4, 2007
Kind
E1
Abstract

Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the identity and/or relative position of one or more amino acids, and in terms of one or more biological and pharmacological properties but which substantially retain other such properties.

Claims (5)

1. [Met- −1 , des-Cys 1 , des-Tyr 2 , des-Cys 3 ] A Met −1 , des - Cys 1 , des - Tyr 2 , des - Cys 3 analog polypeptide of human IFN-γ polypeptide produced encoded by a DNA sequence coding therefor in a transformant organism, said polypeptide having substantially the characteristics of human immune interferon. transformed host cell.

2. A process for producing a Met −1 , des - Cys 1 , des - Tyr 2 , des - Cys 3 analog polypeptide of human IFN - N - γ comprising the steps of

( a ) growing a host cell transformed with a DNA sequence encoding the analog polypeptide, whereby said host cell expresses said DNA sequences, and

( b ) isolating the polypeptide produced by step ( a ) .

3. The process of claim 2 wherein the host cell is E. coli.

Assignments (4)
CHANGE OF NAME Recorded Aug 12, 2015
From: VIDARA THERAPEUTICS INTERNATIONAL PUBLIC LIMITED COMPANY
To: HORIZON PHARMA PUBLIC LIMITED COMPANY
Reel/Frame 036309/0817 →
RELEASE OF SECURITY INTEREST Recorded Apr 2, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 032578/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2012
From: INTERMUNE, INC.
To: VIDARA THERAPEUTICS INTERNATIONAL LIMITED
Reel/Frame 029269/0590 →
SECURITY AGREEMENT Recorded Jun 19, 2012
From: AGI THERAPEUTICS PUBLIC LIMITED COMPANY; VIDARA THERAPEUTICS RESEARCH LIMITED
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028401/0688 →